Status:
RECRUITING
ICAS Screen Based on RIC
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Intracranial Atherosclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Intracranial atherosclerosis stenosis (ICAS) is a leading cause of ischemic stroke worldwide and increase the global burden of stroke, especially in the Asian population. Compared with the other strok...
Eligibility Criteria
Inclusion
- The age is above 18 years old;
- Complete head and neck DSA, CTA, MRA or HR-MRI examination within 2 weeks;
- He/She can cooperate with follow-up fundus examination with free movement;
- Signed informed consent.
Exclusion
- Poor quality of fundus images;
- With intracranial mass lesions;
- With severe heart, liver and kidney diseases;
- With pregnancy and lactation.
Key Trial Info
Start Date :
September 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
2100 Patients enrolled
Trial Details
Trial ID
NCT06610578
Start Date
September 5 2024
End Date
September 1 2027
Last Update
October 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, None Selected, China, 100091